Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination

JAMA - Journal of the American Medical Association

Volumn 314, Issue 14, 2015, Pages 1488-1497

  Grijalva, Carlos G ^a,b   Zhu, Yuwei ^a   Williams, Derek J ^a   Self, Wesley H ^a   Ampofo, Krow ^c   Pavia, Andrew T ^c   Stockmann, Chris R ^c   McCullers, Jonathan ^d   Arnold, Sandra R ^d   Wunderink, Richard G ^e   Anderson, Evan J ^f   Lindstrom, Stephen ^a   Fry, Alicia M ^a   Foppa, Ivo M ^g,h   Finelli, Lyn ^g   Bramley, Anna M ^g   Jain, Seema ^g   Griffin, Marie R ^a,b   Edwards, Kathryn M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Geriatric Research Education Clinical Center (GRECC)   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; CHILD; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HOUSEKEEPING GENE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNASEP GENE; SENSITIVITY ANALYSIS; THROAT CULTURE; CLINICAL TRIAL; COMMUNITY-ACQUIRED INFECTIONS; INFANT; INFLUENZA, HUMAN; MIDDLE AGED; MULTICENTER STUDY; PNEUMONIA, VIRAL; PRESCHOOL CHILD; RISK; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VACCINATION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; VACCINATION;

EID: 84944080842     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.12160     Document Type: Conference Paper

References (40)

1. Fiore AE, Uyeki TM, Broder K, et al; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR-8):1-62.
2. Grohskopf LA, Olsen SJ, Sokolow LZ, et al; Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP): United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep. 2014;63(32):691-697.
3. Talbot HK, Zhu Y, Chen Q, Williams JV, Thompson MG, Griffin MR. Effectiveness of influenza vaccine for preventing laboratoryconfirmed influenza hospitalizations in adults, 2011-2012 influenza season. Clin Infect Dis. 2013;56(12):1774-1777.
4. Belshe RB, Edwards KM, Vesikari T, et al; CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356(7):685-696.
5. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36-44.
6. Belongia EA, Shay DK. Influenza vaccine for community-acquired pneumonia. Lancet. 2008;372(9636):352-354.
7. Griffin MR. Influenza vaccination: a 21st century dilemma. SDMed. 2013; (Spec no):110-118.
8. Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis. 2011;203(4):500-508.
9. Treanor JJ, Talbot HK, Ohmit SE, et al; US Flu-VE Network. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis. 2012;55(7):951-959.
10. Staat MA, Griffin MR, Donauer S, et al. Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007. Vaccine. 2011;29(48):9005-9011.
11. Menniti-Ippolito F, Da Cas R, Traversa G, et al; Italian Multicentre Study Group for Drug and Vaccine Safety in Children. Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy. Vaccine. 2014;32(35):4466-4470.
12. Puig-Barberà J, Díez-Domingo J, Arnedo-Pena A, et al. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study. Vaccine. 2012;30(39):5714-5720.
13. Kwong JC, Campitelli MA, Gubbay JB, et al. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis. 2013;57(6):820-827.
14. Castilla J, Godoy P, Domínguez A, et al; CIBERESP Cases and Controls in Influenza Working Group Spain. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis. 2013;57(2):167-175.
15. Ferdinands JM, Gargiullo P, Haber M, Moore M, Belongia EA, Shay DK. Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies. Epidemiology. 2013;24(4):530-537.
16. Jain S, Williams DJ, Arnold SR, et al; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015;372(9):835-845.
17. Jain S, Self WH, Wunderink RG, et al; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med. 2015;373(5):415-427.
18. Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis. 2011;203(9):1309-1315.
19. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine. 2013;31(17):2165-2168.
20. Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013;31(30):3104-3109.
21. FluView: national and regional level outpatient illness and viral surveillance. Centers for Disease Control and Prevention. http://gis.cdc.gov/grasp/fluview/fluportaldashboard.html. Accessed September 15, 2015.
22. Poehling KA, Edwards KM, Weinberg GA, et al; New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31-40.
23. Cherian T, Mulholland EK, Carlin JB, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005;83(5):353-359.
24. Cowling BJ, Fang VJ, Nishiura H, et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis. 2012;54(12):1778-1783.
25. Sundaram ME, McClure DL, VanWormer JJ, Friedrich TC, Meece JK, Belongia EA. Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness. Clin Infect Dis. 2013;57(6):789-793.
26. Kelly H, Jacoby P, Dixon GA, et al; WAIVE Study Team. Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case-control study. Pediatr Infect Dis J. 2011;30(2):107-111.
27. Cowling BJ, Nishiura H. Virus interference and estimates of influenza vaccine effectiveness from test-negative studies. Epidemiology. 2012;23(6):930-931.
28. Fry AM, Goswami D, Nahar K, et al. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial. Lancet Infect Dis. 2014;14(2):109-118.
29. Jain VK, Rivera L, Zaman K, et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med. 2013;369(26):2481-2491.
30. Ferdinands JM, Olsho LE, Agan AA, et al; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. J Infect Dis. 2014;210(5):674-683.
31. Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet. 2008;372(9636):398-405.
32. Jackson ML, Yu O, Nelson JC, et al. Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A (H1N1) pandemic. Am J Epidemiol. 2013;178(8):1327-1336.
33. Kostova D, Reed C, Finelli L, et al. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005-2011. PLoS One. 2013;8(6):e66312.
34. Musto P, Carotenuto M. Vaccination against influenza in multiple myeloma. Br J Haematol. 1997;97(2):505-506.
35. Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M. Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev. 2013;10: CD008983.
36. Beck CR, McKenzie BC, Hashim AB, et al. Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis. Influenza Other Respir Viruses. 2013;7(suppl 2):72-75.
37. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol. 2006;35(2):345-352.
38. Fleming DM, Andrews NJ, Ellis JS, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010;64(12):1062-1067.
39. Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36(3):623-631.
40. Flu activity and surveillance. Centers for Disease Control and Prevention. http://www.cdc.gov/flu/weekly/fluactivitysurv.htm. Accessed June 15, 2015.